CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

April 26, 2023

Cameron Kim wins Klein Family Distinguished Teaching Award

Klein Family Distinguished Teaching Award Cameron Kim, PhD Recognizes an outstanding educator. These faculty inspire students to learn and apply knowledge, engage students in the classroom and share their love of engineering. Cameron is passionate about training the next generation of bioengineers [...]